Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in the following ...

Analog Devices, Inc. today announced that the Company's Chief Executive Officer & Chair, Vincent Roche, will discuss business topics and trends at the Morgan Stanley Technology, Media & Telecom ...

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences.

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has closed its previously announced registered direct offering ...

U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Wednesday. The Dow traded down 0 ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

Medtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago. These figures are ...

Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat ...

Allurion Technologies (ALUR) announced that it is relaunching the Allurion Balloon in France after ANSM, the French regulatory authority, ...

The mean of analysts' price targets for Allurion Technologies, Inc. (ALUR) points to a 374.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...

Allurion Technologies, Inc. (ALUR) closed the last trading session at $6.04, gaining 58.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...